SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000891554-99-002063
Filing Date
1999-11-04
Accepted
1999-11-04 00:00:00
Documents
1
Group Members
CHRISTINE FEREREDWARD L. MILSTEINELEANORE SNIDERMANLINDA SINCAVAGELLOYD CONSTANTINEMARCIA RIKLISMARVIN SNIDERMANMILSTEIN HOWARD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A SC 13D/A 3443
  Complete submission text file 0000891554-99-002063.txt   5838
Mailing Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Subject) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-33655 | Film No.: 99741065
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DOUGLAS ELLIMAN 575 MADISON AVENUE NEW YORK NY 10022
Business Address C/O DOUGLAS ELLIMAN 575 MADISON AVENUE NEW YORK NY 10022 2128917200
MILSTEIN HOWARD (Filed by) CIK: 0001048530 (see all company filings)

IRS No.: 102389155